NRx Pharmaceuticals (NRXP) Revenue & Revenue Breakdown
NRx Pharmaceuticals Revenue Highlights
0
Latest Revenue (Q)
$242.00K
NRx Pharmaceuticals Revenue by Period
NRx Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | - |
NRx Pharmaceuticals generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
NRx Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $242.00K | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $4.00K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $8.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | - |
NRx Pharmaceuticals generated $242.00K in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
NRx Pharmaceuticals Revenue Breakdown
NRx Pharmaceuticals Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 25 |
|---|---|
| Therapy | $152.00K |
Latest
NRx Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Therapy (100.00%).
NRx Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics | $145.24M | $44.04M |
| EQ | Equillium | $41.09M | - |
| IPSC | Century Therapeutics | $6.59M | - |
| CUE | Cue Biopharma | $5.49M | $2.95M |
| SPRB | Spruce Biosciences | $4.91M | - |
| HOWL | Werewolf Therapeutics | $1.89M | - |
| COEP | Coeptis Therapeutics | - | $62.87K |
| OTLK | Outlook Therapeutics | - | - |
| IOBT | IO Biotech | - | - |
| NRXP | NRx Pharmaceuticals | - | $242.00K |
| SNTI | Senti Biosciences | - | - |